| Literature DB >> 36005040 |
Donato Calabria1,2, Martina Zangheri1,3,4, Seyedeh Rojin Shariati Pour1, Ilaria Trozzi1, Andrea Pace1, Elisa Lazzarini1, Maria Maddalena Calabretta1, Mara Mirasoli1,2,5, Massimo Guardigli1,2,5.
Abstract
The presence of hidden allergens in food products, often due to unintended contamination along the food supply chain (production, transformation, processing, and transport), has raised the urgent need for rapid and reliable analytical methods for detecting trace levels of such species in food products. Indeed, food allergens represent a high-risk factor for allergic subjects due to potentially life-threatening adverse reactions. Portable biosensors based on immunoassays have already been developed as rapid, sensitive, selective, and low-cost analytical platforms that can replace analyses with traditional bench-top instrumentation. Recently, aptamers have attracted great interest as alternative biorecognition molecules for bioassays, since they can bind a variety of targets with high specificity and selectivity, and they enable the development of assays exploiting a variety of transduction and detection technologies. In particular, aptasensors based on luminescence detection have been proposed, taking advantage of the development of ultrasensitive tracers and enhancers. This review aims to summarize and discuss recent efforts in the field of food allergen analysis using aptamer-based bioassays with luminescence detection.Entities:
Keywords: allergen; aptamer; biosensor; chemiluminescence; fluorescence; food
Mesh:
Substances:
Year: 2022 PMID: 36005040 PMCID: PMC9405952 DOI: 10.3390/bios12080644
Source DB: PubMed Journal: Biosensors (Basel) ISSN: 2079-6374
Commercially available LFIAs for food allergens.
| Commercial Name | Allergen or Food | Limit of Detection (ppm) | Company | Reference |
|---|---|---|---|---|
| 3M Rapid Kit | Almond | 2 | 3M | [ |
| Cashew | 2 | |||
| Coconut | 2 | |||
| Egg | 0.5 | |||
| Fish | 1 | |||
| Gluten | 5 | |||
| Hazelnut | 2 | |||
| Milk | 3 | |||
| Peanut | 1 | |||
| Pecan | 3 | |||
| Pistachio | 2 | |||
| Soy | 2 | |||
| Walnut | 2 | |||
| Agitest | Almond | 1 | Rega Biotechnology Inc. | [ |
| Buckwheat | 1 | |||
| Casein | 100 | |||
| Egg | 1 | |||
| Fish | 0.1 | |||
| Gluten | 20 | |||
| Mango | 2 | |||
| Peanut | 1 | |||
| Sesame | 0.2 | |||
| Shellfish | 1 | |||
| Soy | 10 | |||
| AgraStrip | Almond | 2 | Romer Labs GmbH | [ |
| B-Lactoglobulin | 0.5 | |||
| Brazil Nut | 5 | |||
| Casein | 1 | |||
| Cashew/Pistachio | 2 | |||
| Crustacean | 2 | |||
| Coconut | 10 | |||
| Gluten | 4 | |||
| Hazelnut | 5 | |||
| Lupin | 10 | |||
| Macadamia Nut | 2 | |||
| Milk | 1 | |||
| Mustard | 2 | |||
| Peanut | 1 | |||
| Sesame | 5 | |||
| Soy | 2 | |||
| Walnut | 10 | |||
| Whole Egg | ||||
| AlerTox Sticks | Almond | 20 | Hygiena LLC | [ |
| Β-Lactoglobulin | 2.5 | |||
| Casein | 2.5 | |||
| Crustacean | 10 | |||
| Egg | 1.25 | |||
| Fish | 5 | |||
| Hazelnut | 20 | |||
| Milk | 2.5 | |||
| Mustard | 2 | |||
| Peanut | 1 | |||
| Sesame | 3 | |||
| Soy | 10 | |||
| Walnut | 2.25 | |||
| Aller-ROSA | Milk | 2–5 | Charm Sciences Inc. | [ |
| Reveal/Reveal 3D | Almond | 1 | Neogen Co. | [ |
| Coconut | 1 | |||
| Crustacean | 1–5 | |||
| Egg | 2.4 | |||
| Gliadin | 5 | |||
| Gluten | 5–10 | |||
| Hazelnut | 0.75–1.5 | |||
| Milk | 2 | |||
| Multi-Tree nuts | 1–2 | |||
| Mustard | 1.3 | |||
| Peanut | 1.3 | |||
| Sesame | 1 | |||
| Soy | 2.5 | |||
| SENSIStrip | Almond | 1 | Eurofin Technologies | [ |
| Casein | 20 | |||
| Shellfish | 1 | |||
| Egg | 1 | |||
| Fish | 1 | |||
| Peanut | 1 | |||
| Soy | 10 | |||
| Gluten | 2 |
Selection of oligonucleotide aptamers for food allergens reported in the literature.
| Allergen | Aptamer Sequence | Reference |
|---|---|---|
| Ara h 1 1 | (5’) TCG CAC ATT CCG CTT CTA CCG GGG GGG TCG AGC GAG TGA GCG | [ |
| Arginine kinase 2 | (5’) GGC GAA CAG CAG CGC GAT TCG GGT TGC GGA TAG TGA CAT A (3’) | [ |
| β-Conglutin 3 | (5’) AGC TGA CAC AGC AGG TTG GTG GGG GCT TCC AGT TGG GTT GAC AAT ACG TAG GGA CAC GAA GTC CAA CCA CGA GTC GAG CAA TCT CGA AAT (3’) | [ |
| Gluten 4 | (5’) CCA GTC TCC CGT TTA CCG CGC CTA CAC ATG TCT GAA TGC C (3’) | [ |
| (5’) CTA GGC GAA ATA TAG CTA CAA CTG TCT GAA GGC ACC CAA T (3’) | [ | |
| β-Lactoglobulin 5 | (5’) CGA CGA TCG GAC CGC AGT ACC CAC CCA CCA GCC CCA ACA TCA TGC CCA TCC GTG TGT G (3’) | [ |
| Lysozyme 6 | (5’) ATC TAC GAA TTC ATC AGG GCT AAA GAG TGC AGA GTT ACT TAG (3’) | [ |
| (5’) ATC AGG GCT AAA GAG TGC AGA GTT ACT TAG (3’) | [ | |
| (5’) GGG AAT GGA TCC ACA TCT ACG AAT TCA TCA GGG CTA AAG AGT GCA GAG TTA CTT AGT TCA CTG CAG ACT TGA CGA AGC TT (3’) | [ | |
| (5’) GCA GCT AAG CAG GCG GCT CAC AAA ACC ATT CGC ATG CGG C (3’) | [ | |
| Parvalbumin 7 | (5’) GCC AAA GGA GGC GAG AGA TAA AAG ATT GCG AAT CCA TTC G (3’) | [ |
| Tropomyosin 8 | (5’) TAC TAA CGG TAC AAG CTA CCA GGC CGC CAA CGT TGA CCT AGA AGC ACT GCC AGA CCC GAA CGT TGA CCT AGA AGC (3’) | [ |
1 Peanut. 2 Crustaceans. 3 Lupin. 4 Wheat, barley, and rye. 5 Milk. 6 Egg whites. 7 Fish. 8 Crustaceans and mollusks.
Figure 1Processes for producing (a) aptamers and (b) antibodies and a comparison of their main characteristics.
Figure 2Preanalytical procedures needed for bioassays and for conventional laboratory analyses.
Figure 3(a) Schematic illustration of the magnetic-assisted fluorescent aptamer assay for tropomyosin detection. Reprinted with permission from Ref. [68]). Copyright 2022, Elsevier. (b) (A) Schematic illustration of the “on-off-on” fluorescence aptasensor for adenine kinase detection; (B) Recovery of fluorescence intensity upon the addition of shellfish AK and the consequent release of the cCQD-aptamer from the GO surface forming cCQD-aptamers-AK complex. Reprinted with permission from Ref. [38]). Copyright 2022, Elsevier.(c) Schematic illustration of the dual-mode aptasensor for parvalbumin . Reprinted with permission from Ref. [46])]. Copyright 2022, Elsevier. (d) Schematic illustration of the platinum(II) complex-based “switch-on” fluorescent assay for kanamycin. Reprinted with permission from Ref. [75]. Copyright 2022, Elsevier.
Figure 4(a) Schematic illustration of the multiplex antibiotic detection based on the aptamer-modified ABEI-AuNFsReprinted with permission from Ref. [93]). Copyright 2022, Royal Society of Chemistry. (b) Schematic representation of the label-free CL aptasensor for the simultaneous detection of ATP (adenosine triphosphate) and chloramphenicol. Reprinted with permission from Ref. [96]. Copyright 2022, Elsevier.
Scheme of the luminescent aptasensors for food allergen detection reported in the literature.
| Detection Method | Mechanism | Label | Analyte | Detection Limit | Ref. |
|---|---|---|---|---|---|
high potential sensitivity availability of many efficient FL dyes that can be used as labels simple analytical procedures previous development of FL detection systems for other analytical formats an optical module is required, comprising a light source, optics (e.g., lenses or dichroic mirrors), and wavelength selectors (e.g., interference filters) the measurement cell must meet specific requirements in terms of geometry to achieve optimal sample excitation and emitted light collection | The capture aptamer was conjugated on the surface of MNPs. When the aptamer interacts with target analytes, it was released from the surface of MNPs, thus producing a fluorescent signal by adding the OliGreen dye, which is able to enhance its fluorescence upon binding to ssDNA. | Label-free | Tropomyosin | 0.077 µg mL−1 | [ |
| Label-free fluorescent approach was exploited by utilizing the OliGreen ssDNA reagent to quantitatively detect the aptamers bound to analyte in solution with the aid of the adsorption of unfolded aptamers by GO. | Label-free | Tropomyosin | 0.15 μg mL−1 | [ | |
| A fluorescein dye-labeled GO quenches the truncated DNA aptamer. After the addition of the target analyte, the fluorescence was restored due to the competitive binding of the aptamer to GO. | Fluorescein dye | Tropomyosin | 2.5 nmol L−1 | [ | |
| The formation of QD-DNA aptamer–GO complexes as probes is able to undergo conformational change upon interaction with the target analytes, resulting in fluorescence changes: fluorescence is quenched or recovered depending on the adsorption and desorption of aptamer-QDs on GO. | QDs | Ara h 1 | 56 ng mL−1 | [ | |
| The aptamer was immoblized on MNPs, and the C-dots served as a label for the cDNA. The aptamer preferentially binds the target analyte, leading to a partial release of the C-dots-cDNA into the solution. After magnetic separation, the solution contained the released C-dots-cDNA, which are quantified by fluorescence. | C-dots | β-lactoglobulin | 37 pg mL−1 | [ | |
| QDs-DNA aptamer probe and GO were self-assembled to effectively quench the fluorescence of the Qdots. Upon adding the target analyte, the QDs-aptamer was released from the GO surface and formed the QDs–aptamers–analyte complex, leading to a fluorescent signal. | QDs | Arginine kinase | 0.14 ng mL−1 | [ | |
| The aptamer is composed of two partially cDNA arms, each labeled with either a donor (Cy3) or an acceptor (Cy5) fluorophore to enable FRET when the complementary arms hybridize to one another. | Donor (Cy3) and acceptor (Cy5) fluorophore to enable FRET | Lysozyme | 30 nmol L−1 | [ | |
| The probe was represented by a dimeric aptamer, with each monomeric aptamer being flanked by donor/acceptor moieties. Upon addition of target analyte, the specific interaction induces a change in the biaptameric structure, resulting in an increase in fluorescence emission. | Donor (Alexa Fluor 488) and acceptor (Alexa Fluor 555) fluorophore to enable FRET | β-conglutin | 150 pmol L−1 | [ | |
| The assay was based on the use of two fluorogenic peptide aptamers that instantaneously enhance their fluorescence upon binding to a target molecule. | Label free | αs-casein | 0.04 μmol L−1 | [ | |
| The aptasensor was based on hybridization of the DNA aptamer-modified AuNP, the complementary short chain-modified gold nanoparticles and the fluorescent dye-labeled complementary short chain. The presence of target analyte led to a competition, which allows to observe a change in the solution color of the AuNPs and a recovery of the fluorescence signals of FAM-CS2. | AuNP (colorimetric detection) and Fluorescent dye (fluorescent detection) | Parvalbumin | 0.72 μg mL−1 | [ | |
| The assay was based on a square–planar luminescent platinum(II) complex and the DNA aptamer. Upon the addition of the target analyte, the aptamer changes from a random-coiled structure into a specific conformation containing a hairpin region, allowing the intercalation of the platinum(II) complex into the bound aptamer and enhancing the luminescence signal. | Label-free | Kanamycin | 140 nmol L−1 | [ | |
high sensitivity due to the weakness of the background signal CL measurements can be performed with very simple instrumentation (i.e., no light source or wavelength selectors are needed) and using a variety of light detectors No requirements for sample geometry The addition of the chemical reagents that trigger the CL reaction requires a biosensing device equipped with a dedicated fluidic system and complicates the analytical protocol. | The assay employed a capture probe, obtained by immobilizing a biotinylated chloramphenicol-specific aptamer on avidin-modified MNPs, and a detection probe consisting of c-DNA sequence-conjugated ABEI-functionalized AuNFs. The analyte and the detection probe compete for binding to the capture probe, followed by magnetic separation of the capture probe and the addition of CL substrate to trigger the CL reaction. | ABEI-AuNFs | Chloramphenicol | 0.01 ng mL−1 | [ |
| Aptamers specific for the target analytes, acting as capture probes, were immobilized in the wells of a microtiter plate; then, the sample was added to the wells together with detection probes consisting of c-DNA modified with ABEI-functionalized AuNFs. After the competition of the analytes and the detection probes for binding to the immobilized aptamers, the bound detection probes were detected by CL. | ABEI-AuNFs | Oxytetracyclin, tetracycline and kanamycin | 0.02 ng mL−1 (oxytetracycline), 0.02 ng mL−1 (tetracycline) and 0.002 ng mL−1 (kanamycin). | [ | |
| The assay was performed in a streptavidinated microtiter plate coated with a biotin-functionalized capture DNA aptamer and was based on the competition between the analyte in the sample and a tracer (a sulfamethazine ana-log conjugated to the CL enzyme HRP) for binding to the capture aptamer, followed by CL detection of the bound tracer. | HRP | Sulfamethazine | 0.92 ng mL−1 | [ | |
| DNA aptamers specific for the target analyte were immobilized on MBs and hybridized with a complementary oligonucleotide sequence labeled with AuNC. In the presence of the target analyte, its interaction with the aptamer resulted in the release of the AuNC-labeled oligonucleotide sequences. The MBs were removed by magnetic separation; then, the released oligonucleotide sequences were detected. | AuNCs | Kanamycin | 0.035 nmol L−1 | [ | |
| Oligonucleotide capture probes for ATP- and chloramphenicol-binding aptamers were immobilized on polystyrene and magnetic microspheres, respectively. The competition between the analytes and the immobilized capture probes for binding to the aptamers resulted in amounts of aptamer bound to the microspheres that are inversely proportional to the analyte concentrations. The bound aptamers were detected thanks to the CL reaction of the guanine DNA nucleobase with phenylglyoxal and N,N-dimethylformamide. | Label free | ATP and chloramphenicol | 37.6 nmol L−1 (ATP) and 24.8 nmol L−1 (chloramphenicol) | [ | |
The CL emission is triggered by the application of a suitable potential to electrodes embedded in the measurement cell rather than by the addition of a chemical reagent, providing an easier control of light emission in both space and time. Instability of electrode (degradation biosensing reagents and the instable optical signal of ECL luminophores). | A 3D graphene-modified electrode was coated with AuNPs, then functionalized with a lysozyme binding aptamer hybridized with a complementary single-stranded DNA sequence labeled by RuSiNPs@PLL-Au, which acted as an ECL signal amplifier. In the presence of lysozyme, the cDNA sequence of the duplex was displaced by lysozyme, resulting in weaker ECL emission. | RuSiNPs@ PLL-Au | Lysozyme | 7.5 × 10−13 mol L−1 | [ |
| Sample was incubated with probes immobilized at Au electrode in order to form the aptamer–lysozyme bioaffinity complexes, and the free probes were hybridized with the biotin modified cDNA oligonucleotides to form double-stranded DNA (ds-DNA) oligonucleotides. Avidin-QDs were bound to these hybridized cDNA through the biotin–avidin system. The ECL signal of the biosensor was responsive to the amount of QDs bonded to the cDNA oligonucleotides, which was inverse proportional to the combined target protein. | QDs | Lysozyme | Not reported | [ |
Comparison between the analytical performance (in terms of LOD) of luminescence-based aptasensors and commercially available LFIAs for selected food allergens.
| Food Allergen | Aptasensor | LFIA | ||
|---|---|---|---|---|
| LOD 1 | Ref. | LOD 2 | Ref. | |
| Ara h 1 | 56 µg L−1 | [ | 0.5 mg L−1 (detects Ara h 1, Ara h 2, and Ara h 3) | [ |
| Casein | 1 mg L−1 | [ | 0.3 mg L−1 | [ |
| 0.25 mg L−1 | [ | |||
| 1.8 mg L−1 | [ | |||
| 0.03 mg L−1 | [ | |||
| β-Lactoglobulin | 37 ng L−1 | [ | 0.25 mg L−1 | [ |
| Tropomyosin | 77 µg L−1 | [ | 1.7 µg L−1 | [ |
| 0.15 mg L−1 | [ | |||
| 90 µg L−1 | [ | |||
1 LOD values expressed in mole units were converted using the molecular weight of the target allergen protein. 2 In commercial LFIA assays, target allergens are often referred to as generic “food proteins”. To make the comparison significant, here, we reported only LFIAs in which the allergen protein is clearly specified, and a LOD for the protein in the solution is given or can be estimated from the food sample treatment protocol (it has been assumed that the extraction of the protein from the food matrix was quantitative).